Evonik Industries (EVK) Given a €40.00 Price Target at Baader Bank

Evonik Industries (FRA:EVK) received a €40.00 ($46.51) price objective from Baader Bank in a research note issued to investors on Monday. The firm presently has a “buy” rating on the stock. Baader Bank’s price target would suggest a potential upside of 26.50% from the stock’s current price.

EVK has been the subject of a number of other research reports. JPMorgan Chase & Co. set a €27.00 ($31.40) price objective on shares of Evonik Industries and gave the stock a “sell” rating in a research note on Wednesday, July 18th. Independent Research set a €34.00 ($39.53) price objective on shares of Evonik Industries and gave the stock a “neutral” rating in a research note on Wednesday, July 18th. Warburg Research set a €38.00 ($44.19) price objective on shares of Evonik Industries and gave the stock a “buy” rating in a research note on Wednesday, July 18th. Morgan Stanley set a €38.00 ($44.19) price objective on shares of Evonik Industries and gave the stock a “buy” rating in a research note on Monday, July 2nd. Finally, equinet set a €39.00 ($45.35) price objective on shares of Evonik Industries and gave the stock a “buy” rating in a research note on Friday, June 22nd. Four analysts have rated the stock with a sell rating, six have assigned a hold rating and twelve have given a buy rating to the stock. The stock has an average rating of “Hold” and an average price target of €34.90 ($40.58).

Evonik Industries stock traded down €0.09 ($0.10) during midday trading on Monday, reaching €31.62 ($36.77). The stock had a trading volume of 562,862 shares. Evonik Industries has a twelve month low of €26.78 ($31.14) and a twelve month high of €32.97 ($38.34).

About Evonik Industries

Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.

Further Reading: NASDAQ Stock Market Explained

Analyst Recommendations for Evonik Industries (FRA:EVK)

Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply